Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHOS/SHP615 in Pediatric Status Epilepticus Extension
NCT03336450Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam in status epilepticus (SE), sponsored by Takeda. Started Apr 2018; status: completed.
02
Drugs
midazolam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT03336450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336450.